Specific Research :
Cancer epigenomics: identification of novel tumor suppressor genes (TSG) and their functional/mechanistic characterization in tumorigenesis
Identification of epigenetic modifier genes involved in aberrant CpG methylation and chromatin-remodeling in tumors
Development of epigenetic biomarkers and epigenetic therapeutics
Epigenetic regulation of EBV genes and EBV-modulated aberrant epigenetic programming in EBV pathogenesis